[HTML][HTML] Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment
E Rossi, G Schinzari, G Tortora - Journal for Immunotherapy of …, 2020 - ncbi.nlm.nih.gov
Pneumonitis is a rare but serious adverse event caused by cancer immunotherapy. The
diagnosis between COVID-19-induced pneumonia and immunotherapy-induced …
diagnosis between COVID-19-induced pneumonia and immunotherapy-induced …
COVID-19 pneumonia and immune-related pneumonitis: critical issues on differential diagnosis, potential interactions, and management
M Russano, F Citarella, A Napolitano… - Expert opinion on …, 2020 - Taylor & Francis
Introduction The COVID-19 pandemic occurred amid the cancer immunotherapy revolution.
Immune checkpoint inhibitors (ICIs) have become the standard of care for several solid …
Immune checkpoint inhibitors (ICIs) have become the standard of care for several solid …
[HTML][HTML] COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma …
A Dipasquale, P Persico, E Lorenzi… - … for Immunotherapy of …, 2021 - ncbi.nlm.nih.gov
By the beginning of the global pandemic, SARS-CoV-2 infection has dramatically impacted
on oncology daily practice. In the current oncological landscape, where immunotherapy has …
on oncology daily practice. In the current oncological landscape, where immunotherapy has …
Differentiation of COVID-19 pneumonitis and ICI induced pneumonitis
DW Dumoulin, HA Gietema, MS Paats… - Frontiers in …, 2020 - frontiersin.org
Immune checkpoint inhibitors (ICI) have become the standard of care treatment for several
tumor types. ICI-induced pneumonitis is a serious complication seen with treatment with …
tumor types. ICI-induced pneumonitis is a serious complication seen with treatment with …
[HTML][HTML] Overlap of immunotherapy-related pneumonitis and COVID-19 pneumonia: diagnostic and vaccine considerations
MB Abid - Journal for Immunotherapy of Cancer, 2021 - ncbi.nlm.nih.gov
The clinically indistinguishable overlap between pneumonitis caused due to immune
checkpoint inhibition (ICI) and pneumonia associated with COVID-19 has posed …
checkpoint inhibition (ICI) and pneumonia associated with COVID-19 has posed …
Rapidly fatal pneumonitis from immunotherapy and concurrent SARS-CoV-2 infection in a patient with newly diagnosed lung cancer
CM Lovly, KL Boyd, PI Gonzalez-Ericsson, CL Lowe… - MedRxiv, 2020 - medrxiv.org
Immune checkpoint inhibitors (ICIs) are used for the treatment of numerous cancers, but
risks associated with ICI-therapy during the COVID-19 pandemic are poorly understood. We …
risks associated with ICI-therapy during the COVID-19 pandemic are poorly understood. We …
[HTML][HTML] COVID-19 and immune checkpoint inhibitors: initial considerations
COVID-19 infections are characterized by inflammation of the lungs and other organs that
ranges from mild and asymptomatic to fulminant and fatal. Patients who are …
ranges from mild and asymptomatic to fulminant and fatal. Patients who are …
Checkpoint inhibitor pneumonitis mimicking COVID-19 infection during the COVID-19 pandemic
As of May 27, 2020, 5,612,601 people have been diagnosed with COVID-19 and 349,060
deaths have been recorded, with a mortality rate of up to 6.22% worldwide. Despite the …
deaths have been recorded, with a mortality rate of up to 6.22% worldwide. Despite the …
Potential protective and therapeutic role of immune checkpoint inhibitors against viral infections and COVID-19
L Gatto, E Franceschi, VD Nunno, AA Brandes - Immunotherapy, 2020 - Taylor & Francis
Conclusion The COVID-19 pandemic represents a unique challenge but also a learning
opportunity. The complex immune responses for patients on immunotherapy treatment …
opportunity. The complex immune responses for patients on immunotherapy treatment …
Immune checkpoint inhibitors for cancer therapy in the COVID-19 era
M Maio, O Hamid, J Larkin, A Covre, M Altomonte… - Clinical Cancer …, 2020 - AACR
The potential immune intersection between COVID-19 disease and cancer therapy raises
important practical clinical questions and highlights multiple scientific gaps to be filled …
important practical clinical questions and highlights multiple scientific gaps to be filled …
相关搜索
- checkpoint inhibitors covid 19
- cancer treatment covid 19
- treatment of patients covid 19
- covid 19 infection
- differential diagnosis covid 19
- covid 19 pandemic
- promising avenue covid 19
- critical issues covid 19
- checkpoint inhibitors cancer treatment
- checkpoint inhibitor pneumonitis
- checkpoint inhibitors cancer therapy
- checkpoint inhibitors viral infections